Mesenchymal stem cell therapy for severe COVID-19

Mesenchymal stem cell therapy for severe COVID-19

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health authorities. Although the virological characteristics and pathogenesis of COVID-19 has been largely clarified, there is currently no s...

Full description

Bibliographic Details
Main Authors: Lei Shi, Lifeng Wang, Ruonan Xu, Chao Zhang, Yunbo Xie, Kai Liu, Tiantian Li, Wei Hu, Cheng Zhen, Fu-Sheng Wang
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00754-6

Internet

https://doi.org/10.1038/s41392-021-00754-6

Similar Items